Arax Advisory Partners’s Clover Health Investments CLOV Stock Holding History

Arax Advisory Partners’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.4K	Buy	4,653 +3,040	+188%	+$10.3K	﹤0.01%	3822
2026 Q1	$2.84K	Buy	1,613 +89	+6%	+$193	﹤0.01%	2999
2025 Q4	$3.58K	Sell	1,524 -43	-3%	-$118	﹤0.01%	3023
2025 Q3	$4.8K	Buy	+1,567	New	+$4.48K	﹤0.01%	2884
2025 Q1	–	Sell	-1,524	Closed	-$4.8K	–	2734
2024 Q4	$4.8K	Hold	1,524	–	–	﹤0.01%	1755
2024 Q3	$4.3K	Hold	1,524	–	–	﹤0.01%	1781
2024 Q2	$1.88K	Buy	+1,524	New	+$1.37K	﹤0.01%	1986

Other funds holding CLOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Arax Advisory Partners's CLOV Position: Q2 2026 in Review

Arax Advisory Partners increased its Clover Health Investments (CLOV) stake by 188% in Q2 2026, buying an estimated $10.3K and bringing the position to 4,653 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3822.

Arax Advisory Partners first reported a position in CLOV in Q2 2024 and has held it in 7 quarters since. 225 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

Arax Advisory Partners held 4,653 shares of Clover Health Investments worth $24.4K as of Q2 2026.
Arax Advisory Partners bought 3,040 Clover Health Investments shares in Q2 2026, an estimated $10.3K.
Clover Health Investments made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3822 holding.
Arax Advisory Partners first reported a position in Clover Health Investments in Q2 2024 and has held it in 7 quarters since.
225 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.